Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons

Abstract Idiopathic pulmonary fibrosis (IPF) represents a clinical and therapeutic challenge characterized by progressive fibrosis and destruction of the lung architecture. The pathogenesis of IPF has been long debated; while it is generally believed that repeated lung injury and abnormal wound repa...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Pulmonary Therapy
المؤلفون الرئيسيون: Giacomo Giulianelli, Elisabetta Cocconcelli, Giordano Fiorentù, Nicol Bernardinello, Elisabetta Balestro, Paolo Spagnolo
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Adis, Springer Healthcare 2025-05-01
الموضوعات:
Idiopathic pulmonary fibrosis
IPF
Lung fibrosis
Interstitial lung disease
ILD
Clinical trials
الوصول للمادة أونلاين:https://doi.org/10.1007/s41030-025-00296-0

الانترنت

https://doi.org/10.1007/s41030-025-00296-0

مواد مشابهة